Skip to main content
SpringerLink
Log in

Gestational Diabetes Screening After HAPO: Has Anything Changed?

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy. It is defined as diabetes that is first recognized during pregnancy. The diagnosis of GDM is important because it impacts maternal health care during and after pregnancy. The American Diabetes Association, American Congress of Obstetrics and Gynecology, the World Health Organization, and the National Diabetes Data Group all have recommendations for screening; however, there is no consensus. The Hyperglycemia and Adverse Pregnancy Outcome Research Cooperative Study Group published their findings that show hyperglycemia has a significant effect on pregnancy outcome. In addition, recent studies showed that treatment of mild hyperglycemia may affect adverse outcomes. However, at this time no new guidelines for screening and diagnosis of gestational diabetes have been published. This article summarizes the current state of screening for gestational diabetes

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ACHOIS:

Australian Carbohydrate Intolerance Study in Pregnant Women

HAPO:

Hyperglycemia and Adverse Pregnancy Outcome

NICHD:

National Institute of Child Health and Human Development

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Jovanovic L, Pettitt D: Gestational diabetes mellitus. JAMA 2001, 286:2516–2518.

    Article  CAS  PubMed  Google Scholar 

  2. Metzger BE, Coustan DR: Summary and recommendations of the Fourth International Workshop-Conference on gestational diabetes mellitus. Diabetes Care 1998, 21(Suppl 2):B161–B167.

    PubMed  Google Scholar 

  3. Cheung NW, Byth K: Population health significance of gestational diabetes. Diabetes Care 2003, 26:2005–2009.

    Article  PubMed  Google Scholar 

  4. • Landon MB, Spong CY, Thom E, et al.: A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009, 361:1339–1348. Landon et al. showed that treatment of mild hyperglycemia had a significant effect on perinatal outcomes.

  5. Crowther CA, Hiller JE, Moss JR, et al.: Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005, 352:2477–2485.

    Article  CAS  PubMed  Google Scholar 

  6. Yang X, Hsu-Hage B, Zhang H, et al.: Women with impaired glucose tolerance during pregnancy have significantly poor pregnancy outcomes. Diabetes Cares 2009, 25:1619–1623.

    Article  Google Scholar 

  7. Vambergue A, Nuttens MC, Verier-Mine O, et al.: Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The Diagest Study. Diabet Med 2000, 17:203–208.

    Article  CAS  PubMed  Google Scholar 

  8. HAPO Study Cooperative Research Group: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009, 58:453–459.

    Article  Google Scholar 

  9. Clausen TD, Mathiesen ER, Hanson T, et al.: High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008, 31:340–346.

    Article  PubMed  Google Scholar 

  10. Yogev Y, Visser GH: Obesity, gestational diabetes and pregnancy outcome. Semin Fetal Neonatal Med 2009, 14:77–84.

    Article  PubMed  Google Scholar 

  11. American Diabetes Association: Gestational diabetes mellitus. Diabetes Care 2003, 26(Suppl 1):S103–S105.

    Google Scholar 

  12. American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics: ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001, 98:525–538.

  13. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose in tolerance. Diabetes 1979, 28:1039–1057.

    Google Scholar 

  14. U.S. Preventive Services Task Force: Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008, 148:759–764.

    Google Scholar 

  15. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Geneva: World Health Organization; 1999.

  16. O’Sullivan JB, Mahan CM: Criteria for oral glucose tolerance test in pregnancy. Diabetes 1964, 13:278–285.

    PubMed  Google Scholar 

  17. Pederson J: Problems and management. In The Pregnant Diabetic and Her Newborn, edn 2. Copenhagen: Munksgaard; 1977:61–71.

  18. • HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al.: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008, 358:1991–2002. The HAPO study is a landmark study delineating the risks of hyperglycemia at values lower than previously thought to have clinical effects.

    Google Scholar 

  19. O’Sullivan JB, Mahan CM, Charles D, et al.: Screening criteria for high risk gestational diabetic patients. Am J Obstet Gynecol 1973, 116:895–900.

    PubMed  Google Scholar 

  20. Carpenter MW, Coustan DR: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982, 144:768–773.

    CAS  PubMed  Google Scholar 

  21. Metzger BE, Buchanan TA, Coustan D, et al. : Summary and recommendations of the Fifth International Workshop-Conference on gestational diabetes mellitus. Diabetes Care 2007, 30:S251–S259.

    Article  CAS  PubMed  Google Scholar 

  22. Coustan DR, Nelson C, Carpenter M, et al.: Maternal age and screening for gestational diabetes: a population based study. Obstet Gynecol 1989, 73:557–561.

    CAS  PubMed  Google Scholar 

  23. Ferrera A, Hedderson MM, Quesenberry CP, Selby JV: Prevalence of gestational diabetes mellitus detected by the National Diabetes Data Group or the Carpenter and Coustan Plasma Glucose Thresholds. Diabetes Care 2002, 25:1625–1630.

    Article  Google Scholar 

  24. Cheng YW, Block-Kurbish I, Caughey AB: Carpenter-Coustan criteria compared with National Diabetes Data Group thresholds for gestational diabetes mellitus. Obstet Gynecol 2009, 114:326–332.

    Article  PubMed  Google Scholar 

  25. Schmidt MI, Duncan BB, Reichlt AJ, et al.: Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 2001, 24:1151–1155.

    Article  CAS  PubMed  Google Scholar 

  26. Sereday MS, Damiano MM, Gonzalez CD: Diagnostic criteria for gestational diabetes in relation to pregnancy outcome. J Diabetes Complications 2003,17:115–119.

    Article  PubMed  Google Scholar 

  27. Kautzky-Willer A, Bancher-Todesca D, Weitgasser R, et al.: The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women. J Clin Endcrinol Metab 2008, 93:1689–1695.

    Article  CAS  Google Scholar 

  28. Naylor CD, Sermer M, Chen E, et al.: Selective Screening for gestational diabetes mellitus: the Toronto Trihospital Gestational Diabetes Project. N Engl J Med 1997, 337:1591–1596.

    Article  CAS  PubMed  Google Scholar 

  29. Moses RG, Cheung NW: Point: Universal screening for gestational diabetes mellitus. Diabetes Care 2009, 32:1349–1351.

    Article  PubMed  Google Scholar 

  30. Yogev Y, Metzger BE, Hod M: Establishing the diagnosis of gestational diabetes; Impact of the hyperglycemia and adverse pregnancy outcome study. Semin Fetal Neonatal Med 2009, 14:94–100.

    Article  PubMed  Google Scholar 

  31. Berger H, Sermer M: Counterpoint: Selective screening for gestational diabetes mellitus. Diabetes Care 2009, 32:1352–1354.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of OB/GYN, Temple University School of Medicine, 3401 North Broad Street, Philadelphia, PA, 19140, USA

    Wadia R. Mulla, Tasmia Q. Henry & Carol J. Homko

Authors
  1. Wadia R. Mulla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tasmia Q. Henry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carol J. Homko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wadia R. Mulla.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mulla, W.R., Henry, T.Q. & Homko, C.J. Gestational Diabetes Screening After HAPO: Has Anything Changed?. Curr Diab Rep 10, 224–228 (2010). https://doi.org/10.1007/s11892-010-0109-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-010-0109-3

Keywords

Search

Navigation